35th World Summit on COVID-19 (Part VI)
  • Follow

SciTech Central COVID-19 

35th World Summit on COVID-19 (Part VI)

Virtual Seminar

January 10-11, 2023

Register Now

35th World Summit on COVID-19 (Part VI)

After a successful completion of World Summit on COVID-19 (Part V) during July 06-07, 2022, we are initiating SciTech Central COVID-19 (35th World Summit on COVID-19 (Part VI)) is a 2 days seminar scheduled on January 10-11, 2023. The interested speakers are requested to submit abstract and pre-recorded video of the talk. Speakers can be academicians, researchers, scientists, students, faculty members, healthcare executives, doctors etc. The exhibitors are invited to promote their healthcare products at our conference websites.
Most people infected with the Corona virus will experience mild to moderate respiratory problems and recover without any special treatment. Older people and others with any co-morbid are likely to develop serious illness. Anyone can get corona virus and become ill and may die at any age. One can get infected by breathing in the virus from a contaminated region or get in contact with the contaminated surfaces or people. The Corona virus enters the human body through eyes, nose and mouth. The most common symptoms are fever, cough, shortness of breath, tiredness, loss of taste and smell and the less common headaches, sore throat, body aches and diarrhoea.
Covid vaccination provides strong immunity against the corona virus. The vaccinated people are less likely to transfer the disease. Being vaccinated with all the doses does not mean that we are completely safe and can travel anywhere. It may put ourselves and others at risk. For the foreseeable future and to prevent reoccurrence of the virus, we must continue wearing masks, cleaning our hands, ensuring good ventilation indoors, physically distancing and avoiding crowds. 

Discussions on:

  • COVID-19 Vaccination in United States, UK, India, Italy, Australia, Japan etc
  • Efficacy and Safety of Remdesivir
  • Practice of Preventive Measures against COVID-19
  • COVID-19 and New Variants
  • Impact of Hydroxychloroquine Treatment of COVID-19
  • Immune Response to SARS-CoV-2 Variants
  • Analysis of Booster Vaccine to reduce SARS-CoV-2 Infection
  • Resistance Against the Monoclonal Antibodies of Covaxin
  • Sputnik V Efficiency against Delta Variant
  • Pfizer-BioNTech Vaccine for Vulnerable children
  • Covid 19 Pandemic: Mental Health and Well-being of Workforces
  • Secondary Infection in Patients with COVID-19
  • The New Normal in the Society
  • Gullian Barre Syndrome associated with COVID-19 Vaccination
  • Social Isolation in COVID-19 and Mental health
  • Effect of COVID-19 on Educational System
  • Role of Digital Media in COVID-19
  • Psycological Fragility during COVID 19 Pandemic
  • SARS-CoV-2 Transmission in Animals
  • Immunogenicity of COVID-19 Booster Dose
  • Cardiovascular Consequences during and after COVID-19 Infection
  • Impacts of COVID-19 on Tertiary Education: National Responses
  • Social Dimensions of Pandemic
  • Opthalmic Care in COVID-19
  • The Adolescent Support Programme during COVID-19
  • Communication during COVID-19 Vaccination Drive
  • COVID-19 Vaccination and Gender Perspectives
  • COVID-19 in Babies and Children
  • Healthcare Systems and their Struggle
  • Insurance Organizations and their Covers
  • Businesses Benefitted by COVID-19
  • Waste Management during COVID-19 Pandemic
  • COVID-19 in Paediatric Patients
  • Telehealth Encourages during COVID-19
  • Knowledge towards COVID-19 Booster Vaccine
  • Self Efficiency to Manage COVID-19
  • Systemic Diseases during COVID-19 Pandemic
  • Pandemic Responsiveness during Acute Care Setting
  • Misconceptions about COVID-19 Practices
  • Procoagulant Microvesicles in COVID-19 Patients
  • Economic Burden of COVID-19
  • COVID-19 in Veterans
  • COVID-19 and Asthma
  • COVID-19 related Brain Injury
  • Murcormycosis: Post COVID-19 Infection
  • Importance of Efferocytosis in COVID-19 Mortality
  • Community Awareness on COVID-19
  • Infectivity Mechanism of SARS-CoV-2 and its Variants

Accepted Abstracts

Associated Journals


Abstract  Due date: January 05, 2023

Registration Closes: January 09, 2023


Register your interest to keep up to date with the latest information.